肝星状细胞通过产生GDF15促进肝细胞癌生长
本研究探讨肝星状细胞(HSC)在肝细胞癌(HCC)微环境中的作用。在脂肪性肝炎相关肿瘤发生模型中,HSC特异性Atg7或GDF15缺失的小鼠肝脏肿瘤更少更小;体外共培养和异种移植实验表明,HSC自噬依赖性地产生GDF15促进肝癌细胞增殖和肿瘤生长;人类HCC中HSC的GDF15阳性率更高,血清GDF15水平随肿瘤进展升高。结论提示HSC通过自噬依赖性产生GDF15参与HCC进展。
要点
- HSC特异性Atg7缺失减少脂肪性肝炎相关肝癌模型中肿瘤的数量和大小
- HSC自噬依赖性产生GDF15促进肝癌细胞增殖和异种移植瘤生长
- HCC患者HSC中GDF15阳性率高于背景肝,血清GDF15随肿瘤进展升高
核心结论
- 在HCC微环境中,自噬依赖性产生GDF15的HSC增多可能参与肿瘤进展。
研究设计与样本
- 使用链脲佐菌素后高脂饮食诱导的脂肪性肝炎相关肿瘤发生模型。
- HSC特异性Atg7缺陷(GFAP-Atg7 KO)或GDF15缺陷(GFAP-GDF15 KO)小鼠与野生型同窝对照比较。
- 人HSC细胞系LX-2与人肝癌细胞共培养及异种移植实验。
- 对人类HCC组织进行RNA测序和单细胞RNA测序分析,并检测血清GDF15水平。
主要发现
- 在脂肪性肝炎相关肿瘤发生模型中,GFAP-Atg7 KO小鼠形成的肝脏肿瘤比野生型同窝小鼠更少且更小。
- LX-2细胞与肝癌细胞混合培养促进LX-2细胞自噬和肝癌细胞增殖,而LX-2细胞中Atg7 KO可减弱这些效应。
- 肝癌细胞异种移植瘤在LX-2细胞存在时生长迅速,但LX-2细胞中Atg7 KO消除了这种生长。
- RNA测序显示与HepG2细胞共培养的LX-2细胞高表达GDF15,而LX-2细胞中Atg7 KO消除了该表达。
- GDF15 KO的LX-2细胞在体外和异种移植模型中均未显示对肝癌细胞的生长促进作用。
临床怎么用
- HSC来源的GDF15可能作为HCC微环境中的促肿瘤因子,提示靶向HSC自噬或GDF15途径的潜在治疗策略。
- 血清GDF15水平在HCC患者中升高且随肿瘤进展增加,可能有助于疾病监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Although the tumor microenvironment plays an important role in tumor growth, it is not fully understood what role hepatic stellate cells (HSCs) play in the hepatocellular carcinoma (HCC) microenvironment. METHODS: A high-fat diet after streptozotocin was administered to HSC-specific Atg7-deficient (GFAP-Atg7 knockout [KO]) or growth differentiation factor 15 (GDF15)-deficient (GFAP-GDF15KO) mice. LX-2 cells, a human HSC cell line, were cultured with human hepatoma cells. RESULTS: In the steatohepatitis-based tumorigenesis model, GFAP-Atg7KO mice formed fewer and smaller liver tumors than their wild-type littermates. Mixed culture of LX-2 cells and hepatoma cells promoted LX-2 cell autophagy and hepatoma cell proliferation, which were attenuated by Atg7 KO in LX-2 cells. Hepatoma cell xenograft tumors grew rapidly in the presence of LX-2 cells, but Atg7 KO in LX-2 cells abolished this growth. RNA-sequencing revealed that LX-2 cells cultured with HepG2 cells highly expressed GDF15, which was abolished by Atg7 KO in LX-2 cells. GDF15 KO LX-2 cells did not show a growth-promoting effect on hepatoma cells either in vitro or in the xenograft model. GDF15 deficiency in HSCs reduced liver tumor size caused by the steatohepatitis-based tumorigenesis model. GDF15 was highly expressed and GDF15-positive nonparenchymal cells were more abundant in human HCC compared with noncancerous parts. Single-cell RNA sequencing showed that GDF15-positive rates in HSCs were higher in HCC than in background liver. Serum GDF15 levels were high in HCC patients and increased with tumor progression. CONCLUSIONS: In the HCC microenvironment, an increase of HSCs that produces GDF15 in an autophagy-dependent manner may be involved in tumor progression.
引用
- Myojin Y, Hikita H, Sugiyama M, et al. Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production. Gastroenterology. 2020. PMID: 33346004. doi:10.1053/j.gastro.2020.12.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。